I have just had my 6 monthly BCr and am pleased that it is still ZERO. My consultant at Poole only has about 12 patients with CML and I am the only one with a ZERO response. He has reduced my Glivec dosage from the standard 400mg daily to 200mg. I wondered if anyone else has tried a reduced Glivec dosage and, if so, what were the results. e.g. did BCr stay at zero and did you feel any better?
You are here
Reducing Glivec Dose
Dear John,
I am a little worried.. not to say astonished... that your consultant has reduced your dose from the internationlly agreed recommended dose of 400mg imatinib for chronic stage CML down to 200mg. It is generally agreed that adult doses of imatinib under 350mg are sub-optimal.
What were the reasons he gave you for reducing your dose?
Sandy
Hi Sandy,
He seemed to think that, as I have enjoyed a complete molecular response for nearly four years that it was worth trying either a holiday or reduction in dose. As I said, I am the only patient he has with such a good response but I did say that I had been suffering a bit from stomach problems (probably nothing to do with Glivec). Other than saving the NHS some money I can't see any other reason for reducing the dose.
He wants to check again in 4 months to see how I'm doing and seemed confident that, if we start to see an increase, it will return to zero when the dose is increased again.
Can you give me any reference for the recommended dose of 400mg? I will probably discuss it with him further. He is a very nice chap and is quite happy for his patients to contact him if they have any concerns.
Best wishes, John
Dear John,
Go to News on main menu and scroll down to near the bottom of the page to find this interview:
Making History, Making Progress
Brian J. Druker, MD
March 26, 2008 •
DR. Brian DRUKER:
Scroll down to page 9 for Dr. Druker's opinion of lowering doses of imatinib. He is very cautious without first testing for blood plasma trough levels.........see quote below
"Now it also earns some caution in that I would certainly not recommend lowering doses below about 400 milligrams, unless there was very good rationale to do that, plus some supporting data. The supporting data I would be looking for is drug level. And through the CML Alliance, which is a Novartis sponsored program, we can now do drug level monitoring. We can actually find out whether a patient who is having severe side effects with Gleevec®, maybe their drug levels are too high, maybe we could get by with a slightly lower dose. So if we monitor a drug level, we can actually tailor a patient’s dose to acceptable drug level. We certainly know that if we lower drug levels below a certain threshold, we might select for resistance. So that’s why I would advocate being very careful about lowering doses, doing that with a physician
who has some experience with what those levels should be and can help guide people through treatment."
Sandy
Hi John,
Don't do it!!!
How fast can you run? Get away from him as quickly as possible.
Lowering the dose is absolutely the wrong thing to do. It has been shown that you can/will develop resistance to Gleevec.
If you want to go off Gleevec because you have been PCRU for 4 years then I would suggest that you join one of the clinical trials that are testing this very idea. Some early results from these trials show that half the participants relapsed and had to restart Gleevec.
He wants to check after 4 months to see if you relapsed??? Every other researcher who tried this in the past checked on a monthly basis and the moment the CML was detected the patient restarted Gleevec.
Again,
Find someone else to treat your CML!!!!
Zavie
Zavie Miller (age 71)
67 Shoreham Avenue
Ottawa, Canada, K2G 3X3
dxd AUG/99
INF OCT/99 to FEB/00, CHF
No meds FEB/00 to JAN/01
Gleevec since MAR/27/01 (400 mg)
CCR SEP/01. #102 in Zero Club
2.8 log reduction Sep/05
3.0 log reduction Jan/06
2.9 log reduction Feb/07
3.6 log reduction Apr/08
3.6 log reduction Sep/08
3.7 log reduction Jan/09
3.8 log reduction May/09
3.8 log reduction Aug/09
e-mail: zmiller@sympatico.ca
Tel: 613-726-1117
Fax: 613-482-4801
Cell: 613-282-0204
Yahoo ID: zaviem
I completely agree with everything that Zavie has said!
I am also PCRu-U & have been for several years with just the occasional slight positive bounce.
reducing the Glivec dosage could lead to resistance.
My Dr is conducting the clinical study in which people who have been PCR-U consistently for 2 years are able to stop their Glivec but they get their PCR checked EVERY month, not after 4 months!
Hi Sandy & Zavie,
Thank you both for your responses which have certainly given me much food for thought.
Zavie, you say "It has been shown that you can/will develop resistance to Gleevec." Can you give me any links to technical reports which confirm that?
While I was happy to cooperate in a low risk trial to see if I could use a lower dose of Glivec I am not prepared to risk the possibility of resistance.
Sandy, it is a pity that this didn't come up at the recent discussions on Long Term Survivorship. I suppose this shows that reducing dosage is not on anyone's agenda, probably for the reasons you refer to.
Best wishes to you both, John
Dear John
I am sure your doctor would understand your worries regarding possible resistance with sub-optimal doses of imatinib. I do not think you need to find another doctor... after all you are very happy with the treatment you have had so far and as you say, he is very approachable.
My only worry is, as I indicated in my first post, that you are not being monitored often enough..i.e every month. I do not think gaps of 4 months between pcr tests is wise.
Professor John Goldman, Dr. Tim Hughes, Dr. Druker, Prof. Michele Baccarani amongst others have just launched the International CML Foundation. This initiative will support haematologists understanding of the issues surrounding monitoring cml patients on long term TKI therapy. Take a look at the website... it might be a good link for your doctor.
What is the ICMLF?
It is a Foundation established by a group of hematologists with a strong interest in CML. ?Our mission is to improve the outcomes for patients with CML globally. We are currently registered as a charitable foundation in England and Wales but our charter is global.
Sandy
Sandy
I have just tried to click on your link to the cml foundation, but it doesn't seem to be working?
Regards, Janet
Hi Janet, I googled cml foundation & its the 3rd one down
Dear John, Thankfully I have a history of 0 PCR's (on Glivec 8 years). Recently my Consultant told me that fifty percent of patients with 0 PCR's revert to a higher PCR again after taking a Glivec holiday. My Consultant will not even reduce my dose from 600 mg to 400 mg ~ not that I want to because I feel safer this way despite some side effects. As Sandy said I also find the four month wait for another PCR a risky idea. I hope your situation gets sorted out to your liking very soon ~ keep smiling and keep being an educated patient. With best wishes.
I had a telephone chat with my consultant today and we have agreed that, for the time being, I will stay on 400mg per day. Although I am the only patient he has with CCR he says that he knows several patients who are doing well on 200mg per day. He is going to come back to me with more information. I also spoke to Leukaemia Research and was unable to find any hard facts on dosages of Glivec below 400mg.
Thank you all for your advice. John
I have been on 400mg since April 2007 and for the past two years my PCR has ranged between 0.002% and 0.008%. The doc at Hammersmith suggested that this was an order better than was necessary and that I could go down to 300mg with perhaps a small increase in PCR and reduced side effects. They would then do a PCR test every six weeks until they were sure it was OK. She said they have several patients who have done this successfully.
That was back in January. I didn't do it because my side effects are not that bad and I was heading for some major surgery and didn't want to risk complications. However, the surgery is over and I may reconsider it next year.
John
Hi John, i am jamal, i have cml since 2010, and suffer from many side effects.
I read that u decreased the dose so what happened since?
wish everything is ok with u now.
Hi Jamal,
My situation is not quite straightforward. I stopped Imatinib 400mg for some six months at the start of 2014 because I developed macular oedema following lens replacements, which showed signs of having been been triggered/agravated by Imatinib, but I shall never be sure. I went back onto Imatinib 300mg and my PCR is not quite as low as before, but still very acceptably low. I have not noticed any change in side effects, but then they were mild on 400mg. I'm afraid that doesn't help you much, but I can only tell you what happened to me.
P.S. An afterthought. During my first year on Imatinb the side effects were bad. Then my body seemed to settle down and the side effects became slight. When I stopped Imatinib for six months, apart from an improvement in the macular oedema, I did not notice any marked change. When I went back on to 300mg Imatinib, there was a slow but steady improvement in my PCR results. I did notice some minor side effects for a short while, but they subsided.
Best wishes,
John
Really?? Suggest you might want to read about the DESTINY trial and which I'm on. In that trial you go on half dose... so 200mg for a year with monthly MONTHLY monitoring and because it's known that there's risks of reduction. I'd be suggesting that your consultant waits until that trial has completed and full results are known and published before taking any chance. Even then 4 monthly monitoring is insufficient. I know that from experience and from information that has been shared via the trial. My consultant fortunately has a lot of experience with CML